Holen Sie sich die Stockscreener-App
1.45
0.69%
0.01
Handel nachbörslich:
1.45
Schlusskurs vom Vortag:
$1.44
Offen:
$1.46
24-Stunden-Volumen:
1.61M
Relative Volume:
0.67
Marktkapitalisierung:
$385.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-208.38M
KGV:
-1.2083
EPS:
-1.2
Netto-Cashflow:
$-156.57M
1W Leistung:
-7.64%
1M Leistung:
-39.08%
6M Leistung:
-20.77%
1J Leistung:
-64.63%
1-Tages-Spanne:
$1.40
$1.46
1-Wochen-Bereich:
$1.39
$1.5882
52-Wochen-Spanne:
$1.105
$5.00
Autolus Therapeutics Plc Adr Stock (AUTL) Company Profile
Firmenname
Autolus Therapeutics Plc Adr
Sektor
Branche
Telefon
44 20 3829 6230
Adresse
THE MEDIAWORKS, LONDON
Vergleichen Sie AUTL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AUTL
Autolus Therapeutics Plc Adr
|
1.45 | 375.26M | 0 | -208.38M | -156.57M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Autolus Therapeutics Plc Adr Stock (AUTL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-18 | Hochstufung | Goldman | Neutral → Buy |
| 2024-11-15 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-03-27 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-03-17 | Eingeleitet | Bryan Garnier | Buy |
| 2021-06-14 | Hochstufung | Jefferies | Hold → Buy |
| 2021-01-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-12-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-07-31 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-22 | Eingeleitet | SunTrust | Buy |
| 2020-04-22 | Eingeleitet | Mizuho | Buy |
| 2019-09-23 | Eingeleitet | Needham | Buy |
| 2019-05-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-10-24 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Autolus Therapeutics Plc Adr Aktie (AUTL) Neueste Nachrichten
Autolus Therapeutics Q2 Earnings Call Highlights Growth and Challenges - AInvest
Real time pattern detection on World Acceptance Corporation stockJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Aug Macro: What is the next catalyst for The Toronto Dominion BankRate Cut & Reliable Momentum Entry Alerts - khodrobank.com
How to track smart money flows in BNZIJuly 2025 Volume & AI Optimized Trade Strategies - Newser
PLOW recovery potential after sell offWeekly Investment Report & Growth Oriented Trading Recommendations - Newser
Price momentum metrics for HIG.PRG explainedMarket Trend Report & Growth Focused Entry Reports - Newser
Analyzing recovery setups for Autolus Therapeutics plc Depositary Receipt investorsRate Hike & High Accuracy Buy Signal Tips - Newser
Applying Elliott Wave Theory to Travel + Leisure Co.July 2025 Rallies & Comprehensive Market Scan Reports - Newser
AUTL’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Can machine learning forecast MNDR recoveryJuly 2025 EndofMonth & Real-Time Sentiment Analysis - Newser
What makes TFIN stock price move sharplyJuly 2025 Macro Moves & Advanced Technical Signal Analysis - Newser
Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) Given Average Recommendation of “Buy” by Brokerages - Defense World
Q3 EPS Forecast for Autolus Therapeutics Raised by Analyst - Defense World
Wells Fargo & Company Has Lowered Expectations for Autolus Therapeutics (NASDAQ:AUTL) Stock Price - Defense World
Cetera Investment Advisers Raises Stock Position in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) - Defense World
Autolus Therapeutics (NASDAQ:AUTL) Shares Down 3.5% After Analyst Downgrade - Defense World
Autolus reports $20.9 million in Q2 2025 AUCATZYL revenue - Investing.com India
Will Albertsons Companies Inc. stock recover after recent dropFree Entry and Exit Strategy Optimizer Tool - Newser
Autolus Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates - GlobeNewswire Inc.
How GLDD stock performs during market volatilityAlgorithmic Forecast for Swing Trading Picks - Newser
Autolus Therapeutics Q2 2025 Earnings Call Transcript - MarketBeat
Why IGNEP stock attracts strong analyst attentionFree Day Trading Signals With High Precision - Newser
When is the best time to buy GRAIL LLC stockFree Smart Allocation Stock Pick Insights - Newser
Is a relief rally coming for Zhibao Technology Inc. holdersSmart Stock Forecast Using AI Algorithms - Newser
Statistical indicators supporting GDV.PRH’s strengthFree Stable Entry High Return Opportunities - Newser
Can machine learning forecast Peoples Bancorp of North Carolina Inc. recoveryHigh Win Rate Strategy with Stop Protection - Newser
What makes Boqii Holding Limited Depositary Receipt stock price move sharplyFree Market Entry and Exit Point Tips - Newser
Autolus Therapeutics plc ADR: Weathering Stock Market Storms with 637.41M Market Cap - investchronicle.com
LyondellBasell Industries NV (LYB) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Top chart patterns to watch in Stevanato Group S.p.A.Free High Return Stock Focus With Safety - Newser
P 500Real-Time Equity Price Action Analysis - Newser
Unlocking Oncology’s Future: 3 Trending Cancer Biotech Stocks With ‘Strong Buy’ Ratings - Barchart.com
TER’s Stock Market Adventure: -40.87% YTD Growth Amidst Volatility - investchronicle.com
Globe Life Inc (GL) Stock: Navigating a Year of Volatility - investchronicle.com
Autolus Therapeutics’ (AUTL) Buy Rating Reaffirmed at Needham & Company LLC - Defense World
European Commission approves Autolus’ cell therapy for adult leukemia By Investing.com - Investing.com South Africa
European Commission approves Autolus’ cell therapy for adult leukemia - Investing.com India
Will A Mark Precious Metals Inc. stock benefit from interest rate changesDaily Upside Movement Prediction With Data - Newser
Autolus Therapeutics Grants Stock Options to 60 Employees Under 2025 Inducement Plan - Nasdaq
Cambridge Investment Research Advisors Inc. Sells 2,160 Shares of Invesco KBW Property & Casualty Insurance ETF (NASDAQ:KBWP) - Defense World
Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World
1,867 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Bought by DAVENPORT & Co LLC - Defense World
DAVENPORT & Co LLC Trims Holdings in Janus Henderson Short Duration Income ETF (NYSEARCA:VNLA) - Defense World
Vontobel Holding Ltd. Lowers Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) - Defense World
Allspring Global Investments Holdings LLC Raises Holdings in Broadstone Net Lease, Inc. (NYSE:BNL) - Defense World
Wealth Enhancement Advisory Services LLC Takes $258,000 Position in Taylor Morrison Home Corporation (NYSE:TMHC) - Defense World
Vontobel Holding Ltd. Buys 49,643 Shares of Tilray Brands, Inc. (NASDAQ:TLRY) - Defense World
TELUS International (Cda) (TSE:TIXT) Trading 2.1% Higher – What’s Next? - Defense World
Closing Figures: Autolus Therapeutics plc ADR (AUTL)’s Negative Finish at 2.05, Down -3.30 - DWinneX
NOV Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Autolus shares surge 77% following InvestingPro’s April Fair Value signal By Investing.com - Investing.com India
Finanzdaten der Autolus Therapeutics Plc Adr-Aktie (AUTL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):